Depressive and anxiety symptoms among schizophrenia patients
Journal of Affective Disorders · 2024
DOI: 10.1016/j.jad.2024.07.130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2024. Verfasst von Mingzhe Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Mental Health Center & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Schizophrenia, Depression, Anxiety, Antipsychotic Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: University Nursing Program for Young Scholar with Creative Talents in Heilongjiang Province.
Abstract (Originalsprache)
BACKGROUND: Depressive and anxiety symptoms commonly manifested throughout the progression of schizophrenia. However, the prevalence of these symptoms, alongside their co-occurrence, remains uncertain, and clinical correlates remain elusive. OBJECTIVES: This study seeks to investigate the prevalence of such symptoms and their demographic and clinical associations among patients diagnosed with schizophrenia. METHODS: The study included 19,623 patients diagnosed with schizophrenia based on the ICD-10 criteria. Participants were recruited from community-dwelling patients registered in the local health system in Hangzhou of China between August 1 and October 30, 2022. RESULTS: The prevalence rates of depressive and anxiety symptoms, as well as their co-occurrence, were determined to be 19 % (95%CI = 18.5-19.6 %), 37.4 % (95%CI = 36.8-38.0 %), and 17.7 % (95%CI = 17.2-18.2 %), respectively. Patients prescribed quetiapine, olanzapine, and risperidone exhibited significantly lower prevalence rates of these symptoms (P < 0.01). Spearman's correlation analysis revealed a significant correlation between depressive symptoms and anxiety symptoms (r = 0.60, P = 0.006). Additionally, age, social relationships, and sleep status were significantly associated with depressive and anxiety symptoms, and their co-occurrence, in both univariate and multivariate analyses. CONCLUSION: Given the pervasive nature and detrimental consequences of these symptoms among individuals diagnosed with schizophrenia, comprehensive evaluation and implementation of efficacious interventions are highly recommended.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Affiliated Mental Health Center & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- School of Early Childhood Education, Hangzhou Polytechnic, Hangzhou, China.
- Department of Applied Psychology, Education Science Research Institute, Heilongjiang University, Harbin, China.
- Affiliated Mental Health Center & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou, China. Electronic address: drsonghaidong@126.com.
- Affiliated Mental Health Center & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou, China. Electronic address: sunxh_hz@163.com.
Förderung
- University Nursing Program for Young Scholar with Creative Talents in Heilongjiang Province
Zitieren
APA
Zhao, M., Ma, J., Wu, Y., Zhang, Y., Wang, L., Song, H., & Sun, X. (2024). Depressive and anxiety symptoms among schizophrenia patients. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2024.07.130
Vancouver
Zhao M, Ma J, Wu Y, Zhang Y, Wang L, Song H, et al. Depressive and anxiety symptoms among schizophrenia patients. Journal of Affective Disorders. 2024. doi:10.1016/j.jad.2024.07.130
BibTeX
@article{Zhao2024,
author = {Zhao, Mingzhe and Ma, Jingsong and Wu, Yue and Zhang, Yuyin and Wang, Lin and Song, Haidong and Sun, Xiaohua},
title = {Depressive and anxiety symptoms among schizophrenia patients},
journal = {Journal of Affective Disorders},
year = {2024},
doi = {10.1016/j.jad.2024.07.130}
}
EUVIMED